학술논문

Discovery of the Long Interspersed Nuclear Element-1 activation product [Open Reading Frame-1 (ORF1) protein] in human blood.
Document Type
Article
Source
Clinica Chimica Acta. Dec2018, Vol. 487, p228-232. 5p.
Subject
*PROTEINS
*MOBILE genetic elements
*PROSTATE
*ANTIGENS
*PROSTATE cancer
Language
ISSN
0009-8981
Abstract
Abstract Long Interspersed Nuclear Element 1 is the only autonomous mobile DNA capable of self-propagation, and is an environmental biomarker that is activated upon an environmental trigger. We have developed an ELISA method to detect and measure Open Reading Frame-1 (ORF1) and have applied it to interrogate serum samples from men with equivocal prostate specific antigen (PSA) results. Polyclonal antibodies were developed using the first 14-amino acid peptide of N-terminal-ORF1 protein. Remnant serum samples from a total of 53 men, ages>50 yr, were analyzed for immunoreactive ORF1 (iORF1) and PSA concentrations; outcomes for the non-biopsied and biopsied groups were also recorded. The dynamic range of the ELISA was between (CV): 2.0 (14%) to 30 ng/mL (1.2%). The total imprecision (within-run/inter-day) was: QC3 = 2.7%/21%, QC6 = 1.1%/18%, and QC20 = 0.33%/11%. The median iORF1 concentration in the non-biopsy group was 14.7 ng/mL (Q1 – Q3: 10.5 – Q3:18.4), which was significantly lower than the Biopsy group at 25.0 ng/mL (Q1 – Q3: 20.0–33.1), P -value =.003. In conclusion, we have developed a competitive ELISA and discovered the presence of iORF1 in serum, which could be used to advance future studies involving ORF1 measurement from blood. In addition, iORF1 may be a complement with the PSA screen to better detect prostate cancer. Highlights • Discovery of iORF1 in human serum based on a competitive ELISA • iORF1 may be a complement with the PSA screen to better detect prostate cancer • This assay allows differentiation of two groups from an equivocal prostate cancer cohort screened by PSA [ABSTRACT FROM AUTHOR]